Opioid induced adrenal insufficiency: what is new?
- 1 June 2019
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Endocrinology, Diabetes and Obesity
- Vol. 26 (3), 133-138
- https://doi.org/10.1097/med.0000000000000474
Abstract
Despite the declaration of an opioid epidemic, opioid use remains prevalent. Side-effects of chronic opioid use continue to be problematic. Opioid-induced endocrinopathies have been well documented, yet opioid-induced adrenal insufficiency (OIAI) remains underappreciated. This review summarizes what is currently known regarding the prevalence, predictive factors for the development and effect of treatment of OIAI. Although several case reports have highlighted the development of adrenal crisis among those receiving chronic opioids, only a few studies have systematically assessed patients for OIAI. The heterogeneity of these small studies presents challenges when trying to assess prevalence of or potential risk factors for OIAI. The estimated prevalence of OIAI among those treated with chronic opioids ranges from 8.3 to 29% and is more likely in those receiving higher doses of opioids. Reduced health-related quality of life variables and altered pain perception has been associated with lower cortisol levels; however, the effect of glucocorticoid replacement on the parameters remains unknown. Further research is critical to better identify those at greatest risk and guide optimal management of OIAI. Frontline providers should remain vigilant for possibility of OIAI among chronic opioid users.Keywords
This publication has 57 references indexed in Scilit:
- Technical details influence the diagnostic accuracy of the 1 μg ACTH stimulation testActa Endocrinologica, 2010
- The Mu-Opioid Receptor Polymorphism A118G Predicts Cortisol Responses to Naloxone and StressNeuropsychopharmacology, 2005
- Chronic fentanyl application induces adrenocortical insufficiencyJournal of Internal Medicine, 2005
- Influence of acute and chronic morphine or stadol on the secretion of adrenocorticotrophin and its hypothalamic releasing hormone in the ratLife Sciences, 1996
- Diagnosis of adrenal insufficiency.BMJ, 1989
- Differences in Hypothalamo-Pituitary-Adrenocortical Activity in the Rat after Acute and Prolonged Treatment with MorphineNeuroendocrinology, 1984
- ACTH and corticosterone response to naloxone and morphine in normal, hypophysectomized and dexamethasone-treated ratsLife Sciences, 1982
- Analgesic responses to morphine and placebo in individuals with postoperative painPain, 1981
- THE EFFECTS OF A MET‐ENKEPHALIN ANALOGUE ON ACTH, β‐LPH, β‐ENDORPHIN AND MET‐ENKEPHALIN IN PATIENTS WITH ADRENOCORTICAL DISEASEClinical Endocrinology, 1981
- Naloxone Increases ACTH and Cortisol Levels in ManThe New England Journal of Medicine, 1979